Display Settings:

Format

Send to:

Choose Destination
    J Neuroimmunol. 2011 Jan;230(1-2):26-32. Epub 2010 Sep 9.

    T cells that trigger acute experimental autoimmune encephalomyelitis also mediate subsequent disease relapses and predominantly produce IL-17.

    Source

    Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

    Abstract

    Earlier studies showed that donor T cells that initiated a murine adoptive EAE persisted in the CNS of the recipients throughout the subsequent relapsing cycles. To clarify the functions of the persistent donor T cells in EAE relapsing disease, anti-Thy-1 antibodies were used to deplete these cells. Results showed that such treatment abrogated subsequent relapsing cycles in these animals. In addition, it was evident that a shift in cytokine profile occurred during acute and relapsing disease phases. These results unambiguously support the appropriateness of targeting T cells with specificity for the priming antigen in design of therapeutic approaches for MS.

    Copyright © 2010 Elsevier B.V. All rights reserved.

    PMID:
    20826011
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3000891
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk